Autoinflammatory conditions: when to suspect? How to treat?

被引:23
作者
Grateau, Gilles [1 ]
Duruoz, Mehmet Tuncay [2 ]
机构
[1] Univ Paris 06, AP HP, Hop Tenon,Serv Med Interne, Ctr Reference Amyloses Origine Inflammatoire & Fi, F-75970 Paris 20, France
[2] Celal Bayar Univ, Sch Med, Dept Phys Med & Rehabil, Div Rheumatol, TR-45010 Manisa, Turkey
来源
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY | 2010年 / 24卷 / 03期
关键词
auto-inflammation; genetic disease; innate immunity; interleukin-1; amyloidosis; FAMILIAL MEDITERRANEAN FEVER; PERIODIC SYNDROME TRAPS; ACUTE COLCHICINE INTOXICATION; MUCKLE-WELLS-SYNDROME; TNF RECEPTOR; INTERLEUKIN-1-RECEPTOR ANTAGONIST; HYPERIMMUNOGLOBULINEMIA-D; SUBCLINICAL INFLAMMATION; INTERFERON-ALPHA; DIAGNOSTIC-VALUE;
D O I
10.1016/j.berh.2009.12.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The term 'autoinflammatory disease' encompasses an enlarging group of inflammatory disorders defined as Mendelian genetic diseases of the innate immune system. This group is growing considering the fact that diseases sharing strong similarities with this core group can be defined as autoinflammatory. The core group consists now of six disorders also known as hereditary recurrent fever syndromes. Thez most common is familial Mediterranean fever, an autosomal recessive disease affecting mainly populations of Mediterranean ancestry. All these six diseases are characterised by inflammatory attacks both at the clinical and at the biological level. The diagnosis of each of these diseases relies first on clinical features and second on genetic testing, which is guided by the clinical results. Deciphering the role of interleukin-1 in the regulation of the inflammatory response through the inflammasome represents a major advance in the knowledge of the mechanisms of these diseases with, as a main consequence, treatment with interleukin-1 inhibitors. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:401 / 411
页数:11
相关论文
共 66 条
[51]   The inflammasome, autoinflammatory diseases, and gout [J].
Petrilli, Virginie ;
Martinon, Fabio .
JOINT BONE SPINE, 2007, 74 (06) :571-576
[52]  
Sacré K, 2008, J RHEUMATOL, V35, P357
[53]  
SCHOINDRE Y, 2009, JOINT BONE SPIN 0929
[54]  
Seyahi E, 2006, CLIN EXP RHEUMATOL, V24, pS99
[55]   Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes [J].
Simon, A ;
van der Meer, JWM ;
Vesely, R ;
Myrdal, U ;
Yoshimura, K ;
Duys, P ;
Drenth, JPH .
RHEUMATOLOGY, 2006, 45 (03) :269-273
[56]   Beneficial response to interleukin I receptor antagonist in traps [J].
Simon, A ;
Bodar, EJ ;
van der Hilst, JCH ;
van der Meer, JWM ;
Fiselier, TJW ;
Cuppen, MPJM ;
Drenth, JPH .
AMERICAN JOURNAL OF MEDICINE, 2004, 117 (03) :208-210
[57]   Mevalonate kinase deficiency - Evidence for a phenotypic continuum [J].
Simon, A ;
Kremer, HPH ;
Wevers, RA ;
Scheffer, H ;
de Jong, JG ;
van der Meer, JWM ;
Drenth, JPH .
NEUROLOGY, 2004, 62 (06) :994-997
[58]   MEFV analysis is of particularly weak diagnostic value for recurrent fevers in western European Caucasian patients [J].
Tchernitchko, D ;
Moutereau, S ;
Legendre, A ;
Delahaye, A ;
Cazeneuve, C ;
Lacombe, C ;
Grateau, G ;
Amselem, S .
ARTHRITIS AND RHEUMATISM, 2005, 52 (11) :3603-3605
[59]   Colchicine Update: 2008 [J].
Terkeltaub, Robert A. .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2009, 38 (06) :411-419
[60]   Successful treatment of renal amyloidosis due to familial cold autoinflammatory syndrome using an interleukin 1 receptor antagonist [J].
Thornton, Brian D. ;
Hoffman, Hal M. ;
Bhat, Adarsh ;
Don, Burl R. .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2007, 49 (03) :477-481